© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Opus Genetics, Inc. (IRD) shows an Average True Range (ATR) of 0.15 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 520.06K, indicating liquidity. These fundamental metrics provide insight into IRD's underlying financial health and market activity.
Opus Genetics, Inc. (IRD) technical indicators as of December 23, 2025: the SMA 20 is -4.23%, SMA 50 at 0.61%, and SMA 200 at 51.79%. The RSI 14 value is 47.89, suggesting its current momentum. These technical analysis signals help assess IRD's price trends and potential future movements.
Opus Genetics, Inc. (IRD) stock performance overview as of December 23, 2025: The 52-week high is $2.59 (currently -20.48% below), and the 52-week low is $0.65 (currently 216.92% above). Over the past year, IRD's performance is 106%, compared to the S&P 500's 10.56% change.
According to market data, Opus Genetics, Inc. (IRD) stock's recent performance metrics show that over the last month, IRD is 10.75%, with a Year-to-Date (YTD) performance of 73.11%. Over the past year, the stock has seen a 106% change. These figures summarize IRD's price movements across various periods, reflecting its historical returns.
According to current financial data, IRD stock's P/E (TTM) ratio is -2.19, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for IRD, including P/S (8.99), P/B (7.29), and P/FCF (-4.35), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.